Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)
Clinical trial NCT00971126 · TERMINATED
Trial details
- NCT number
- NCT00971126
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-01-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.